Droplet Digital™ PCR (ddPCR™) is a revolutionary technology that has transformed the field of nucleic acid detection and quantification. Since its discovery, ddPCR has been recognized as a game-changing technology that has significantly improved the accuracy and sensitivity of nucleic acid detection. With its ability to deliver precise and reliable data, ddPCR has become a valuable tool in a wide range of applications, such as cell gene therapy, gene expression analysis, rare mutation detection, copy number variation and many more.
Testimonials and Insights
"Droplet digital PCR is a powerful technology that has transformed the field of nucleic acid analysis. Its ability to accurately quantify nucleic acids in complex samples has broad applications in research and clinical diagnostics, including cancer detection and monitoring, infectious disease diagnosis, and prenatal testing."
Dr. Alec Morley,
Director of the Centre for Biomedical Engineering at the University of Auckland
Testimonials and Insights
"By utilizing ddPCR, we can analyze ctDNA levels as early as 3 weeks post-treatment. These results have high prognostic value. We see better outcomes in patients that clear ctDNA than those that do not."
Gary Pestano, PhD,
Chief Development Officer at Biodesix
Testimonials and Insights
"Digital PCR is a transformative technology that has the potential to greatly improve our ability to diagnose and monitor diseases, as well as to advance our understanding of basic biological processes."
Dr. Alec Morley,
Director of the Centre for Biomedical Engineering at the University of Auckland